BACKGROUND: Cannabis use is reported to increase the risk for psychosis, but no prospective study has longitudinally examined drug use and symptoms concurrently in clinical high risk cases. METHOD: We prospectively followed for up to 2 years 32 cases who met research criteria for prodromal psychosis to examine the relationship between substance use and clinical measures. RESULTS: Cases with a baseline history of cannabis use (41%) were older, but did not differ in clinical measures. Longitudinal assessments showed these cases had significantly more perceptual disturbances and worse functioning during epochs of increased cannabis use that were unexplained by concurrent use of other drugs or medications. CONCLUSIONS: These data demonstrate that cannabis use may be a risk factor for the exacerbation of subthreshold psychotic symptoms, specifically perceptual disturbances, in high risk cases.
BACKGROUND: Cannabis use is reported to increase the risk for psychosis, but no prospective study has longitudinally examined drug use and symptoms concurrently in clinical high risk cases. METHOD: We prospectively followed for up to 2 years 32 cases who met research criteria for prodromal psychosis to examine the relationship between substance use and clinical measures. RESULTS: Cases with a baseline history of cannabis use (41%) were older, but did not differ in clinical measures. Longitudinal assessments showed these cases had significantly more perceptual disturbances and worse functioning during epochs of increased cannabis use that were unexplained by concurrent use of other drugs or medications. CONCLUSIONS: These data demonstrate that cannabis use may be a risk factor for the exacerbation of subthreshold psychotic symptoms, specifically perceptual disturbances, in high risk cases.
Authors: Adrian Preda; Tandy J Miller; Joanna Lifshey Rosen; Lubna Somjee; Thomas H McGlashan; Scott W Woods Journal: Psychiatr Serv Date: 2002-03 Impact factor: 3.084
Authors: P Miller; S M Lawrie; A Hodges; R Clafferty; R Cosway; E C Johnstone Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2001-07 Impact factor: 4.328
Authors: Lisa J Phillips; Christina Curry; Alison R Yung; Hok Pan Yuen; Steven Adlard; Patrick D McGorry Journal: Aust N Z J Psychiatry Date: 2002-12 Impact factor: 5.744
Authors: S Sevy; D G Robinson; S Holloway; J M Alvir; M G Woerner; R Bilder; R Goldman; J Lieberman; J Kane Journal: Acta Psychiatr Scand Date: 2001-11 Impact factor: 6.392
Authors: Joanna L Rosen; Tandy J Miller; Jennifer T D'Andrea; Thomas H McGlashan; Scott W Woods Journal: Schizophr Res Date: 2006-05-02 Impact factor: 4.939
Authors: Neeraj Tandon; Debra Montrose; Jai Shah; R P Rajarethinam; Vaibhav A Diwadkar; Matcheri S Keshavan Journal: J Psychiatr Res Date: 2011-11-04 Impact factor: 4.791
Authors: Joseph S DeLuca; Nicole D Andorko; Doha Chibani; Samantha Y Jay; Pamela J Rakhshan Rouhakhtar; Emily Petti; Mallory J Klaunig; Elizabeth C Thompson; Zachary B Millman; Kathleen M Connors; LeeAnn Akouri-Shan; John Fitzgerald; Samantha L Redman; Caroline Roemer; Miranda A Bridgwater; Jordan E DeVylder; Cheryl A King; Steven C Pitts; Shauna P Reinblatt; Heidi J Wehring; Kristin L Bussell; Natalee Solomon; Sarah M Edwards; Gloria M Reeves; Robert W Buchanan; Jason Schiffman Journal: J Psychother Integr Date: 2020-06